Eli Lilly 2006.

Methods	DESIGN Description: Randomised, double blind, placebo‐controlled, parallel fixed dose trial BLINDING Participants: Unclear Assessors: Unclear Administrators: Unclear ALLOCATION CONCEALMENT Method: Unclear RANDOMISATION Method: Unclear
Participants	SAMPLE Description: 411 PTSD SCREENING Primary diagnosis: Unclear Comorbidity: Unclear
Interventions	Description: fluoxetine 20 mg/d (N = 163) and 40 mg/d (N = 160) versus placebo (N = 88) x mean of 84 days
Outcomes	TOP‐8,CGI‐S (no distinction made between primary and secondary outcomes) Data estimation: ITT
Notes	INDUSTRY SUPPORT Industry funded: Yes Medication provided by industry: Yes Any of the authors work for industry: Yes ADDITIONAL INFORMATION Drop‐out rates: 259 (63%) dropouts in total Quality rating score: Not calculated
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment (selection bias)	Unclear risk	B ‐ Unclear